2015
DOI: 10.1111/tan.12650
|View full text |Cite
|
Sign up to set email alerts
|

The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways

Abstract: Diversity within the innate and adaptive immune response to hepatitis C is important in determining spontaneous resolution (SR) and treatment response. The aim of this study was to analyze how these variables interact in combination; furthering our understanding of the mechanisms that drive successful immunological clearance. Multivariate analysis was performed on retrospectively collected data for 357 patients previously genotyped for interferon (IFN)‐λ3/4, killer cell immunoglobulin (KIR), human leukocyte an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 42 publications
(67 reference statements)
1
8
0
Order By: Relevance
“…Of note, while on the genetic level we do not see a beneficial effect for KIR2DL3 and HLA-C1 in our German PWID cohort, we have previously reported that, on a phenotypic level, higher expression of KIR2DL3 is associated with spontaneous immune control of HCV and protection from infection (10). Collectively, the existing data from genetic association studies support the idea that the genetic correlates for "protection" against HCV infection are not universal and that the pathways to immune control involve multiple discrete factors (37). This also includes the genetic determinants of the CD8 + T cell response, that plays an important role in antiviral immunity against hepatitis C. In particular, presence of HLA-B*27 and HLA-B*57 was reproducibly associated with spontaneous immune control of HCV infection (38)(39)(40)(41).…”
Section: Discussionsupporting
confidence: 75%
“…Of note, while on the genetic level we do not see a beneficial effect for KIR2DL3 and HLA-C1 in our German PWID cohort, we have previously reported that, on a phenotypic level, higher expression of KIR2DL3 is associated with spontaneous immune control of HCV and protection from infection (10). Collectively, the existing data from genetic association studies support the idea that the genetic correlates for "protection" against HCV infection are not universal and that the pathways to immune control involve multiple discrete factors (37). This also includes the genetic determinants of the CD8 + T cell response, that plays an important role in antiviral immunity against hepatitis C. In particular, presence of HLA-B*27 and HLA-B*57 was reproducibly associated with spontaneous immune control of HCV infection (38)(39)(40)(41).…”
Section: Discussionsupporting
confidence: 75%
“…Exploratory univariate analysis of associations with co-receptor tropism was performed using the unpaired Students t-Test and Mann-Whitney Wilcoxon for continuous data, and χ 2 -test for categorical data. Subsequently, principal component analysis (PCA) was performed on immunological data, TB status, sex and age in order to account for multicollinearity of immunological marker data and distinguish between discrete immunological pathways 62 . Effect of principal components on X4-tropism was estimated using stepwise backward logistic regression with the first four principal components as independent variables and X4-tropism, defined at an FPR cut-off of ≤ 3.5%, as the dichotomous dependent variable (Table 3).…”
Section: Statistical Data Analysesmentioning
confidence: 99%
“…Different clinical associations have been reported for KIR haplotype A, having being linked to protection against Hodgkin lymphoma and to a higher risk of conversion to acute myeloid leukaemia in myelodysplastic syndromes, while it was found increased in Mycobacterium tuberculosis ‐infected individuals . A recent study has shown that the haplotype B group included genes associated with chronic HCV infection and poor treatment response, but had a minor protective role against end stage manifestations including cirrhosis and hepatocellular carcinoma …”
Section: Discussionmentioning
confidence: 99%